Jean-Philippe Charrier

This inventor holds 32 USPTO granted patents and 5 published patent applications, plus 10 CIPO patents and 22 EPO patents. Top assignees: Biomerieux, Inc., Centre National De La Recherche Scientifique, Biomerieux Sa. Active years: 2005-2025.

USPTO Granted Patents = 32 (Patent Applications = 5)

% Patents Active = 68.8

CIPO Patents = 10 (Patent Applications = 7)

EPO Patents = 22 (Patent Applications = 27)

Average Co-Inventor Count = 4.4

ph-index = 5

Forward Citations = 46(Granted Patents)

Location History:

Ecully, FR (2005 - 2009)
Tassin la Demi-Lun, FR (2018)
Tassin la Demi-Lune, FR (2013 - 2024)

Company Filing History:

Centre National De La Recherche Scientifique

University Claude Bernard Lyon I

Commissariat a L'energie Atomique Et Aux Energies Alternatives

patents

8. 1 out of 46

Hospices Civils De Lyon

patents

where one patent can have more than one assignee

Years Active: 2005-2025

Loading Chart...

Areas of Expertise:

Mass Spectrometry

Microorganism Quantification

Colorectal Cancer Diagnosis

Biological Sample Integrity

Resistance Mechanisms Detection

Peptide Synthesis

Diagnostic Assays

Biological Matter Sampling

Apolipoprotein Assays

Immunological Testing

Prostate Adenocarcinoma

Protein Analysis

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12460243 - Mass spectrometry determination of the sensitivity or resistance of bacteria to an antibiotic (2025-11-04),

2. 12448641 - Method for quantifying at least one microorganism group via mass spectrometry (2025-10-21),

3. 12211681 - Method for determining the integrity of a deposit of a complex based on a biological sample and system for carrying out said method (2025-01-28),

4. 11898192 - Method for quantifying at least one microorganism group via mass spectrometry (2024-02-13),

5. 10670602 - Method for detecting a colorectal lesion (2020-06-02),

6. 10591482 - Method of assaying Apolipoprotein AI for the in vitro diagnosis of colorectal cancer (2020-03-17),

7. 10407711 - Method for obtaining peptides (2019-09-10),

8. 10190148 - Method for obtaining peptides (2019-01-29),

9. 10144948 - Method of sampling and/or depositing a sample of biological matter and device implementing such method (2018-12-04),

10. 10077461 - Method for characterizing at least one microorganism by means of mass spectrometry (2018-09-18),

11. 9995751 - Method for detecting at least one mechanism of resistance to glycopeptides by mass spectrometry (2018-06-12),

12. 9891223 - Method of assaying leukocyte elastase inhibitor for the in vitro diagnosis of colorectal cancer (2018-02-13),

13. 9890196 - Ezrin assay method for the in vitro diagnosis of colorectal cancer (2018-02-13),

14. 9874570 - Method of detecting at least one mechanism of resistance to cephalosporins by mass spectrometry (2018-01-23),

15. 9874568 - Method of detecting at least one mechanism of resistance to carbapenems by mass spectrometry (2018-01-23),

Title: Jean-Philippe Charrier - Innovative Inventor from Tassin la Demi-Lune, FR

Introduction: Jean-Philippe Charrier is a renowned inventor hailing from Tassin la Demi-Lune, France, known for his groundbreaking contributions to various fields.

Latest Patents: Jean-Philippe Charrier holds several patents in the areas of renewable energy, sustainable technologies, and medical devices, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Charrier has consistently pushed the boundaries of innovation, leading to the development of cutting-edge solutions that have made a significant impact on society.

Collaborations: Throughout his career, Jean-Philippe Charrier has collaborated with leading research institutions, universities, and companies worldwide, fostering a culture of innovation and knowledge exchange.

Conclusion: Jean-Philippe Charrier's relentless pursuit of innovation and his passion for creating solutions to complex challenges have solidified his reputation as a visionary inventor in the global innovation landscape.